Owing to the differences in filtration technology and origins of fetal bovine blood, fetal bovine serum prices of different brands are expected to vary in the global market. Sluggish development of the global beef industry is predicted to result into a stable supply of fetal bovine serum in the coming years. However, fetal bovine serum prices are anticipated to increase due to the rigid demand for vaccine and drug research and stem cell research and production.
Since the past few years, the global fetal bovine serum production has shown modest growth because of the lack of raw material supply.
Global Fetal Bovine Serum Market: Drivers and Restraints
The demand for fetal bovine serum has been creeping up despite substantial changes in the sera industry. Aggressive development of the healthcare and biomedical industries is prophesied to augur well for the global sales of fetal bovine serum. Any increase in the growth of the beef industry is also anticipated to reflect positively on the global sales of fetal bovine serum considered as a by-product.
However, the seasonal production of fetal bovine serum is prognosticated to interfere with the growth of the global market. This is because the raw material, i.e. fetal bovine blood can only be acquired twice a year.
Global Fetal Bovine Serum Market: Forecast by Type and Application
The global market is segmented into Australia-sourced, South America-sourced, U.S.-sourced, and others according to type of product.
On the basis of application, the report categorizes the global market into industrial production and scientific research. Fortification of cell culture media is a primary application of fetal bovine serum, which is one of the most common media supplements used in the procedure. Fetal bovine serum is also an irreplaceable media used in the cell culture industry.
Global Fetal Bovine Serum Market: Forecast by Region
The report covers important regions and countries, viz. India, Southeast Asia, Japan, China, Europe, and the U.S.
As per the report, South America, New Zealand, Australia, and North America witness the concentration of manufacturers in the global fetal bovine serum industry. The supply and consumption markets for fetal bovine serum are reasonably different. Followed by Japan, the U.S. and Europe mainly witness the concentration of consumers.
Global Fetal Bovine Serum Market: Competitive Analysis
Followed by GE Healthcare and Merck, Thermo Fisher is the largest manufacturer operating in the global fetal bovine serum industry. Suppliers such as Zhejiang Tianhang Biotechnology and Lanzhou Minhai operating in developing markets are increasing their shares as substitutes are not expected to replace fetal bovine serum in the short term. Fetal bovine serum suppliers are envisaged to increase contracts with beef agents and processors to collect raw materials.
Global Fetal Bovine Serum Market: Key Players
Some of the major players of the global fetal bovine serum market are Bovogen, Tissue Culture Biologicals, Atlanta Biologicals, Gemini, Moregate BioTech, Merck, Sigma-Aldrich, GE Healthcare, Thermo Fisher, and Life Technologies.
The report studies all of the above players and also other prominent ones operating in the global fetal bovine serum industry.
Full Report Overview@ https://www.qyresearch.com/index/detail/161728/global-fetal-bovine-serum-sales-market